Farther Finance Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
Farther Finance Advisors's SBIO Position: Q3 2026 in Review
Farther Finance Advisors held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q3 2026 at 4,978 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.
Farther Finance Advisors first reported a position in SBIO in Q4 2022 and has held it in 16 quarters since. The position peaked at $322K in Q2 2026. 3 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.
- Farther Finance Advisors held 4,978 shares of ALPS Medical Breakthroughs ETF worth $290K as of Q3 2026.
- Farther Finance Advisors left its ALPS Medical Breakthroughs ETF share count unchanged in Q3 2026.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2009 holding.
- Farther Finance Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2022 and has held it in 16 quarters since.
- Farther Finance Advisors's ALPS Medical Breakthroughs ETF position peaked at $322K in Q2 2026.
- 3 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.